尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Bazemore, Robert Jr.. Insider active across 1 company, notably Eupraxia Pharmaceuticals Inc.. Aggregated, 5 reports have been published. History available since 25 June 2026. The latest transaction was disclosed on 25 June 2026 (50 - Grant of options). Regulator: SEDI. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Bazemore, Robert Jr. is a declarant linked to Eupraxia Pharmaceuticals Inc. on XTSE, where he is listed as 4 - Director of Issuer. The record shows 5 filings in total, and the 5 sampled filings are all dated 2026-06-30, with a transaction nature of 00 - Opening Balance-Initial SEDI Report.